Grushenka H.I. Wolfgang

GS-9620, an Oral Agonist of Toll-Like Receptor-7, Induces Prolonged Suppression of Hepatitis B Virus in Chronically Infected Chimpanzees

Robert E. Lanford, Bernadette Guerra, Deborah Chavez et al. · Gastroenterology · 2013 · 367 citations · Full text

Host Response, Viral Hepatitis, Oral Agonist +8

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis

Éric Lefebvre, Graeme Moyle, Ran Reshef et al. · PLoS ONE · 2016 · 306 citations · Full text

Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B

Stephan Menne, Daniel B. Tumas, Katherine H. Liu et al. · Journal of Hepatology · 2015 · 201 citations · Full text

GS-9219—A Novel Acyclic Nucleotide Analogue with Potent Antineoplastic Activity in Dogs with Spontaneous Non–Hodgkin's Lymphoma

Hans Reiser, Jianying Wang, Lee K. Chong et al. · Clinical Cancer Research · 2008 · 87 citations

Predicting human safety: screening and computational approaches

Dale E Johnson, Grushenka H.I. Wolfgang · Drug Discovery Today · 2000 · 77 citations

Engineering, Predictive Analytics, Risk Management +9